Unicameral bone cysts (UBCs) are benign bone lesions that are typically found in children and adolescents. They are characterized by a single cavity filled with fluid and are typically asymptomatic. Although they are considered benign, UBCs can cause significant morbidity if left untreated. The purpose of this article is to provide a comprehensive overview of UBCs, including their epidemiology, clinical presentation, diagnosis, treatment, and prognosis.
UBCs are more commonly seen in children and adolescents, with an estimated incidence of 0.3-2.2 per 100,000 individuals. They are most commonly seen in the long bones of the arms and legs, with the humerus, femur, and tibia being the most commonly affected sites. Boys are more commonly affected than girls, with a male-to-female ratio of 3:1.
UBCs are typically asymptomatic and are often discovered incidentally during radiologic imaging for other conditions. However, they can cause pain, swelling, or tenderness if they are located in a weight-bearing bone or are located near a joint. They can also cause a pathologic fracture if they are located in a weight-bearing bone.
UBCs are typically diagnosed based on radiologic imaging, such as X-ray, CT, or MRI. On radiologic imaging, UBCs appear as well-circumscribed, lytic lesions with a single cavity filled with fluid. The lesions typically have a �ground-glass� appearance on CT or MRI.
The treatment of UBCs depends on the size and location of the lesion. Small, asymptomatic lesions can be monitored with serial radiologic imaging. Larger or symptomatic lesions may require surgical intervention, such as curettage and bone grafting.
The prognosis for UBCs is generally good, with most lesions resolving without treatment. The recurrence rate is estimated to be between 5-10%, and the risk of malignant transformation is very low.
UBCs are benign bone lesions that are typically found in children and adolescents. They are characterized by a single cavity filled with fluid and are typically asymptomatic. Although they are considered benign, UBCs can cause significant morbidity if left untreated. The diagnosis of UBCs is typically made based on radiologic imaging, and the treatment depends on the size and location of the lesion. The prognosis for UBCs is generally good, with most lesions resolving without treatment.
1.
According to the CAPTIVATE Study, fixed-duration ibrutinib plus venetoclax may be beneficial for patients with high-risk chronic lymphocytic leukemia.
2.
Scientists develop novel adjuvant delivery system to enhance cancer vaccine effectiveness
3.
Vepdegestrant Earns FDA Nod for ESR1-Mutated Breast Cancer
4.
According to a study, taking part in a clinical trial for cancer may not actually increase survival.
5.
A new blood test greatly increases the ability to detect cancer.
1.
Cancer Memory: A Persistent Threat to Tumor Recurrence and Metastasis
2.
Unraveling the Mysteries of Hematocrit: How It Impacts Your Health
3.
The Transformative Power of Genomics in the Diagnosis and Management of Rare Cancers
4.
Omega-3 Fatty Acids as Molecular Adjuvants Against Chemoresistance in Breast Cancer
5.
Surprising Symptoms of Prostate Cancer: What You Need to Know
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Navigating the Complexities of Ph Negative ALL - Part X
2.
Efficient Management of First line ALK-rearranged NSCLC - Part III
3.
What Therapy Would Yield the Best Outcomes In Patients with R/R B-cell ALL?
4.
Expert Group meeting with the management of EGFR mutation positive NSCLC - Part IV
5.
Updates on Standard V/S High Risk Myeloma Treatment- The Next Part
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation